Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Tirapazamine |
Synonyms | |
Therapy Description |
Tirazone (tirapazamine) is a hypoxia-activated prodrug that induces DNA damage within hypoxic regions of tumors, potentially providing antineoplastic activity (PMID: 18666379, PMID: 32543771). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Tirapazamine | Tirazone | SR4233|WIN 59075 | Tirazone (tirapazamine) is a hypoxia-activated prodrug that induces DNA damage within hypoxic regions of tumors, potentially providing antineoplastic activity (PMID: 18666379, PMID: 32543771). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02174549 | Phase I | Tirapazamine | Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer | Active, not recruiting | USA | 0 |
NCT03145558 | Phase II | Doxorubicin Tirapazamine | TATE Versus TACE in Intermediate Stage HCC (TATE) | Suspended | USA | 0 |